Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus

Platelets

Volumn 24, Issue 6, 2013, Pages 493-497

  Turgut, Okan ^a   Zorlu, Ali ^a   Kilicli, Fatih ^a   Cinar, Ziynet ^a   Yucel, Hasan ^a   Tandogan, Izzet ^a   Dokmetas, Hatice Sebila ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; diabetes mellitus; mean platelet volume

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINOPATHY; SINUS RHYTHM; SMOKING; THROMBOCYTE VOLUME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84880863244     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.725876     Document Type: Article

References (41)

1. Ostgren CJ, Merlo J, Rastam L, Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004;6:367-374.
2. Lip GY, Varughese GI. Diabetes mellitus and atrial fibrillation: Perspectives on epidemiological and pathophysiological links. Int J Cardiol 2005;105:319-321.
3. Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, Page RL, Heckbert SR. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 2010;25:853-858.
4. Iguchi Y, Kimura K, Shibazaki K, Aoki J, Sakai K, Sakamoto Y, Uemura J, Yamashita S. HbA1c and atrial fibrillation: A crosssectional study in Japan. Int J Cardiol 2012;156:156-159.
5. Mylotte D, Kavanagh GF, Peace AJ, Tedesco AF, Carmody D, O'reilly M, Foley DP, Thompson CJ, Agha A, Smith D. Platelet reactivity in type 2 diabetes mellitus: A comparative analysis with survivors of myocardial infarction and the role of glycaemic control. Platelets 2012;23:439-446.
6. Coban E, Yazicioglu G, Berkant Avci A, Akcit F. The mean platelet volume in patients with essential and white coat hypertension. Platelets 2005;16:435-438.
7. Coban E, Yilmaz A, Sari R. The effect of weight loss on the mean platelet volume in obese patients. Platelets 2007;18:212-216.
8. Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23-28.
9. Choi CU, Seo HS, Kim YK, Na JO, Lim HE, Kim JW, Kim EJ, Rha SW, Park CG, Oh DJ. Can mean platelet volume predict coronary vasospasm? Platelets 2011;22:173-178.
10. Jung DH, Lee HR, Lee YJ, Kim JK, Park BJ, Shim JY. The association between coronary artery calcification and mean platelet volume in the general population. Platelets 2011;22:567-571.
11. Cho SY, Jeon YL, Choi SK, Suh JT, Lee HJ, Park TS. Mean platelet volume in Korean patients with acute ischemic stroke: A gender difference. Platelets 2012, doi:10.3109/09537104. 2012.658109.
12. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammatioñ Curr Pharm Des 2011;17:47-58.
13. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004;15:475-478.
14. Papanas N, Mavridis G, Karavageli E, Symeonidis G, Maltezos E. Peripheral neuropathy is associated with increased mean platelet volume in type 2 diabetic patients. Platelets 2005;16:498-499.
15. Unubol M, Ayhan M, Guney E. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets 2012; 23:475-480.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl. 1):S43-S48.
17. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris III FL, Klein R, American Diabetes Association. Retinopathy in diabetes. Diabetes Care 2004;27(Suppl. 1):S84-S87.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Tavil Y, Sen N, Yazici H, Turfan M, Hizal F, Cengel A, Abaci A. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Platelets 2010;21:368-372.
20. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003;23:2131-2137.
21. Gasparyan AY. Platelets in inflammation and thrombosis. Inflamm Allergy Drug Targets 2010;9:319-321.
22. Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H. Mean platelet volume is elevated during paroxysmal atrial fibrillation: A marker of increased platelet activatioñ Blood Coagul Fibrinolysis 2008;19:411-414.
23. Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983;53:503-511.
24. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-460.
25. Giles H, Smith RE, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994;24:69-72.
26. Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med 1985;105:271-276.
27. Pakala R, Waksman R. Currently available methods for platelet function analysis: Advantages and disadvantages. Cardiovasc Revasc Med 2011;12:312-322.
28. Bancroft AJ, Abel EW, Mclaren M, Belch JJ. Mean platelet volume is a useful parameter: A reproducible routine method using a modified Coulter thrombocytometer. Platelets 2000;11: 379-387.
29. Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77:407-411.
30. Pongratz G, Brandt-Pohlmann M, Henneke KH, Pohle C, Zink D, Gehling G, Bachmann K. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 1997;111:929-933.
31. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, Bovill EG. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 1999;30:2547-2553.
32. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: Relationship to stroke risk factors. Circulation 2002;106:1962-1967.
33. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005;46:284-290.
34. Bath P, Algert C, Chapman N, Neal B, PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35:622-626.
35. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35:1688-1691.
36. Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP. Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 2011;22: 408-414.
37. Yip HK, Chang LT, Sun CK, Yang CH, Hung WC, Hang CL, Wu CJ, Chua S, Yeh KH, Chang HW. Platelet activation in patients with chronic nonvalvular atrial fibrillation. Int Heart J 2006;47:371-379.
38. Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011;108:56-62.
39. Ferroni P, Basili S, Falco A, Davì G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004;2:1282-1291.
40. Wynn RF, Davies SV, Williams K, Trevett DG. The effects of time from venepuncture and choice of anticoagulant on mean platelet volume estimations. Clin Lab Haematol 1995; 17:173-176.
41. Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology 2006; 11:317-319.